EOTTD

European Organisation for Treatment of Trophoblastic Diseases

Trophoblastic Diseases

ESGO supports The European Organisation for Treatment of Trophoblastic Diseases(EOTTD) which has become a special task force under the ESGO umbrella focused on topics related to trophoblastic diseases.

Mission Statement

The European Organisation for Treatment of Trophoblastic Diseases is dedicated to optimize diagnosis, treatment, follow-up and research in Gestational Trophoblastic Disease (GTD) by bringing together knowledge of clinicians and researchers working in the field of GTD in Europe. 

Objectives

The task force’s primary objective is to bring together all European players in the field of GTD. In order to optimize diagnosis, treatment, follow-up and research in GTD four working parties have been established on:

• Pathology
• Genetics
• Guidelines and Clinical management
• hCG assay’s

These working parties set their own goals and report on their proceedings on every annual EOTTD meeting.

Activities

• Annual meeting

         Watch 15 webscasts from the latest EOTTD annual meeting on  ESGO eAcademy.

         Subscribe today to eAcademy and gain free access to view 

         Future perspectives in gestational trophoblastic disease

•  Facilitating establishment of new GTD centers in countries where these do not exist
• Working group meeting at biannual ESGO meeting
• Online tumor board
• Online advisory board
• Online database linked to ISSTD
• Creating formalized consensus on treating of GTD
• Facilitating pan-European research on GTD

Chair

François Golfier, Lyon, France

Members

Michael Seckl, London, UK - m.seckl@imperial.ac.uk
Leon Massuger, Nijmegen, The Netherlands - l.massuger@obgyn.umcn.nl 
Nienke van Trommel, Nijmegen, The Netherlands, Secretary - nienke@vantrommel.nl